Attached files
| file | filename |
|---|---|
| 10-K - 10-K - CASSAVA SCIENCES INC | ptie-20171231x10k.htm |
| EX-31.1 - EX-31.1 - CASSAVA SCIENCES INC | ptie-20171231xex31_1.htm |
| EX-23.1 - EX-23.1 - CASSAVA SCIENCES INC | ptie-20171231xex23_1.htm |
| EX-10.17 - EX-10.17 - CASSAVA SCIENCES INC | ptie-20171231xex10_17.htm |
CERTIFICATIONS OF THE CHIEF EXECUTIVE OFFICER AND THE
CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Remi Barbier, Chairman of the Board of Directors, President and Chief Executive Officer (as Principal Executive Officer and Principal Financial Officer) of Pain Therapeutics, Inc. (the “Company”), hereby certify that to the best of our knowledge:
|
1. |
The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017, and to which this certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, and |
|
2. |
The information contained in this Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: February 6, 2018
/s/ REMI BARBIER
Remi Barbier,
Chairman of the Board of Directors,
President and Chief Executive Officer
(Principal Executive Officer and Principal Financial Officer)